ForSight Robotics Secures $125M in Series B Funding to Revolutionize Robotic Eye Surgery Worldwide

ForSight Robotics is thrilled to announce a major milestone in our journey to revolutionize global eye care, having successfully raised $125,000,000 in our latest funding round. Founded in 2020 by pioneers in surgical robotics, our company is committed to redefining quality surgical eye care with ORYOM, the very first robotic surgery platform specifically designed for cataract procedures and the treatment of widespread eye diseases. With this substantial capital infusion, we are poised to accelerate the development and deployment of breakthrough technologies that harness advanced computer vision, AI-based machine learning, and microsurgical robotics to empower eye surgeons and ultimately transform patient care worldwide. This funding round is not just a financial boost—it is a clear affirmation of the confidence that investors have in our vision to democratize quality surgical eye care and bring hope to millions of patients by restoring sight. The funds will be strategically allocated to enhance our research and development capabilities, expand our clinical trials, and scale up manufacturing processes to meet the growing global demand for more accessible and reliable surgical solutions. Moreover, we plan to broaden our partnerships with leading healthcare institutions and veteran surgeons, securing the necessary expertise and collaboration that will drive the next phase of our innovation. At ForSight Robotics, our mission is anchored in the belief that every individual deserves access to life-changing medical advancements. As we continue to push the envelope in transforming global healthcare through technological innovation, we invite talented and passionate professionals to join our journey. Learn more about our open positions and be part of a team that is truly making a difference in the future of eye care: https://www.linkedin.com/company/forsightrobotics/jobs/